The nuclear factor E2-related factor 2 and age-related macular degeneration.
Arq Bras Oftalmol
; 86(2): 178-187, 2023.
Article
in En
| MEDLINE
| ID: mdl-35417516
After the discovery of anti-vascular endothelial growth factor agents as treatment of wet age-related macular degeneration, the number of studies with the objective to understand the molecular mechanisms involved in the age-re lated macular degeneration genesis has increased. The importance of the nuclear factor e2-related factor 2 lies in its activation-derived proteins being involved in the maintenance of the redox balance and consequent prevention of degenerative macular disease. This article aims to present the characteristics of nuclear factor e2-related factor 2 and describe the main nuclear factor e2-related factor 2-activated antioxidant enzymes that contribute to the preservation of vision.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Angiogenesis Inhibitors
/
Wet Macular Degeneration
Limits:
Humans
Language:
En
Journal:
Arq Bras Oftalmol
Year:
2023
Document type:
Article
Affiliation country:
Brazil
Country of publication:
Brazil